PHIBRO ANIMAL HEALTH CORP (PAHC)
About PHIBRO ANIMAL HEALTH CORP
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.3B
- Net income
- $48.3M
- Total assets
- $1.4B
- Market cap
- $1.3B
- Gross margin
- 30.9%
- Operating margin
- 8.5%
- Net margin
- 3.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.3B
- Cost of revenue
- $896.3M
- Gross profit
- $399.9M
- Operating expenses
- $289.5M
- Operating income
- $110.5M
- Income tax
- $19.7M
- Net income
- $48.3M
- EPS (basic)
- $1.19
- EPS (diluted)
- $1.19
Balance sheet
- Total assets
- $1.4B
- Current assets
- $810.6M
- Total liabilities
- $1.1B
- Current liabilities
- $293.5M
- Shareholders’ equity
- $285.7M
Cash flow
- Operating cash flow
- $80.1M
- Investing cash flow
- -$288.7M
- Financing cash flow
- $207.1M
- Net cash flow
- -$2.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.3B
- P/E ratio
- 28.6
- EPS (diluted)
- $1.19
- Dividend yield
- 1.41%
- Shares outstanding
- 38.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 11, 2014
Phibro Animal Health Corp (PAHC) Stock Price
- Profitable — net income of $48.3M in FY2025.
- Revenue grew 56% from FY2021 to FY2025.
- Gross margin of 30.9%, net margin 3.7%.
- Trading 43% below its 52-week high.
- Pays a dividend yielding about 1.41% annually.
- Valued at a price-to-earnings (P/E) ratio of 28.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PHIBRO ANIMAL HEALTH CORP.
Write a review
News about PHIBRO ANIMAL HEALTH CORP
News & sentiment via Polygon.io
Phibro Animal Health Corp: frequently asked questions
Is Phibro Animal Health Corp an American company?
Phibro Animal Health Corp is a US-based company headquartered in Teaneck, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Phibro Animal Health Corp headquartered?
Phibro Animal Health Corp is headquartered in Teaneck, New Jersey, United States.
Is Phibro Animal Health Corp publicly traded?
Yes — Phibro Animal Health Corp is a publicly traded company. Its stock trades under the ticker symbol PAHC on the NASDAQ.
What does Phibro Animal Health Corp do?
Phibro Animal Health Corp is an American Pharmaceuticals company in the Health & Beauty sector.
